Ronco C, Bellomo R and Kellum JS: Acute kidney injury. Lancet. 394:1949–1964. 2019. View Article : Google Scholar : PubMed/NCBI

Fu Y and Dong Z: Immune response in COVID-19-associated acute kidney injury and maladaptive kidney repair. Integrative Medicine in Nephrology and Andrology. 10:e000222023. View Article : Google Scholar

Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, Goldstein SL, Cerdá J and Chawla LS: Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 14:607–625. 2018. View Article : Google Scholar : PubMed/NCBI

Meena J, Kumar J, Kocharlakota JP, Gupta H, Mittal P, Kumar A, Sinha A, Hari P and Bagga A: Acute kidney injury in neonates: A meta-analysis. Pediatrics. 154:e20230651822024. View Article : Google Scholar : PubMed/NCBI

Gautam SC, Lim J and Jaar BG: Complications associated with continuous RRT. Kidney360. 3:1980–1990. 2022. View Article : Google Scholar : PubMed/NCBI

Zhang R, Widdop RE and Ricardo SD: Transition from acute kidney injury to chronic kidney disease: Mechanisms, models, and biomarkers. Am J Physiol Renal Physiol. 327:F788–F805. 2024. View Article : Google Scholar : PubMed/NCBI

Li J, Duan J, Hua C, Pan S, Li G, Feng Q, Liu D and Liu Z: Nanomedicine embraces the treatment and prevention of acute kidney injury to chronic kidney disease transition: Evidence, challenges, and opportunities. Burns Trauma. 12:tkae0442024. View Article : Google Scholar : PubMed/NCBI

Koh ES and Chung S: Recent update on acute kidney injury-to-chronic kidney disease transition. Yonsei Med J. 65:247–256. 2024. View Article : Google Scholar : PubMed/NCBI

Song Z and Gong X: Research progress on the potential mechanisms of acute kidney injury and chronic kidney disease induced by proton pump inhibitors. Integrative Medicine in Nephrology and Andrology. 10:2023. View Article : Google Scholar

Stanski NL, Rodrigues CE, Strader M, Murray PT, Endre ZH and Bagshaw SM: Precision management of acute kidney injury in the intensive care unit: Current state of the art. Intensive Care Med. 49:1049–1061. 2023. View Article : Google Scholar : PubMed/NCBI

Krishnasamy S, Sinha A and Bagga A: Management of acute kidney injury in critically Ill children. Indian J Pediatr. 90:481–491. 2023. View Article : Google Scholar : PubMed/NCBI

Kou M, Huang L, Yang J, Chiang Z, Chen S, Liu J, Guo L, Zhang X, Zhou X, Xu X, et al: Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: A next generation therapeutic tool? Cell Death Dis. 13:5802022. View Article : Google Scholar : PubMed/NCBI

Allinson CS, Pollock CA and Chen X: Mesenchymal stem cells in the treatment of acute kidney injury (AKI), chronic kidney disease (CKD) and the AKI-to-CKD transition. Integrative Medicine in Nephrology and Andrology. 10:e000142023. View Article : Google Scholar

Sávio-Silva C, Soinski-Sousa PE, Balby-Rocha MTA, Lira ÁO and Rangel ÉB: Mesenchymal stem cell therapy in acute kidney injury (AKI): Review and perspectives. Rev Assoc Med Bras (1992). 13(66 Suppl 1): S45–S54. 2020. View Article : Google Scholar

Lee PW, Wu BS, Yang CY and Lee OK: Molecular mechanisms of mesenchymal stem cell-based therapy in acute kidney injury. Int J Mol Sci. 22:114062021. View Article : Google Scholar : PubMed/NCBI

Khubutiya MS, Vagabov AV, Temnov AA and Sklifas AN: Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury. Cytotherapy. 16:579–585. 2014. View Article : Google Scholar

Han Q, Wang X, Ding X, He J, Cai G and Zhu H: Immunomodulatory effects of mesenchymal stem cells on drug-induced acute kidney injury. Front Immunol. 12:6830032021. View Article : Google Scholar : PubMed/NCBI

Fazekas B and Griffin MD: Mesenchymal stromal cell-based therapies for acute kidney injury: Progress in the last decade. Kidney Int. 97:1130–1140. 2020. View Article : Google Scholar : PubMed/NCBI

Zhao L, Hu C, Han F, Wang J and Chen J: Regenerative abilities of mesenchymal stem cells via acting as an ideal vehicle for subcellular component delivery in acute kidney injury. J Cell Mol Med. 24:4882–4891. 2020. View Article : Google Scholar : PubMed/NCBI

Birtwistle L, Chen XM and Pollock C: Mesenchymal stem cell-derived extracellular vesicles to the rescue of renal injury. Int J Mol Sci. 22:65962021. View Article : Google Scholar : PubMed/NCBI

Mukkala AN, Jerkic M, Khan Z, Szaszi K, Kapus A and Rotstein O: Therapeutic effects of mesenchymal stromal cells require mitochondrial transfer and quality control. Int J Mol Sci. 24:157882023. View Article : Google Scholar : PubMed/NCBI

Jiang D, Chen FX, Zhou H, Lu YY, Tan H, Yu SJ, Yuan J, Liu H, Meng W and Jin ZB: Bioenergetic Crosstalk between mesenchymal stem cells and various ocular cells through the intercellular trafficking of mitochondria. Theranostics. 10:7260–7272. 2020. View Article : Google Scholar : PubMed/NCBI

Paliwal S, Chaudhuri R, Agrawal A and Mohanty S: Regenerative abilities of mesenchymal stem cells through mitochondrial transfer. J Biomed Sci. 25:312018. View Article : Google Scholar : PubMed/NCBI

Michaeloudes C, Li X, Mak JCW and Bhavsar PK: Study of mesenchymal stem cell-mediated mitochondrial transfer in in vitro models of oxidant-mediated airway epithelial and smooth muscle cell injury. Methods Mol Biol. 2269:93–105. 2021. View Article : Google Scholar : PubMed/NCBI

Iorio R, Petricca S, Mattei V and Monache SD: Horizontal mitochondrial transfer as a novel bioenergetic tool for mesenchymal stromal/stem cells: Molecular mechanisms and therapeutic potential in a variety of diseases. J Transl Med. 22:4912024. View Article : Google Scholar : PubMed/NCBI

Zhao L, Hu C, Zhang P, Jiang H and Chen J: Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury. J Cell Mol Med. 23:720–730. 2019. View Article : Google Scholar :

Zhao L, Hu C, Zhang P, Jiang H and Chen J: Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury. Stem Cell Res Ther. 9:2252018. View Article : Google Scholar : PubMed/NCBI

Makkar D, Gakhar D, Mishra V and Rakha A: Fine tuning mesenchymal stromal cells-code for mitigating kidney diseases. Stem Cell Rev Rep. 20:738–754. 2024. View Article : Google Scholar : PubMed/NCBI

Fu Z, Zhang Y, Geng X, Chi K, Liu C, Song C, Cai G, Chen X and Hong Q: Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury. Stem Cell Res Ther. 14:1162023. View Article : Google Scholar : PubMed/NCBI

Yang Y, Lee EH and Yang Z: Hypoxia-conditioned mesenchymal stem cells in tissue regeneration application. Tissue Eng Part B Rev. 28:966–977. 2022. View Article : Google Scholar

Yasan GT and Gunel-Ozcan A: Hypoxia and hypoxia mimetic agents as potential priming approaches to empower mesenchymal stem cells. Curr Stem Cell Res Ther. 19:33–54. 2024. View Article : Google Scholar

Li H, Ji XQ, Zhang SM and Bi RH: Hypoxia and inflammatory factor preconditioning enhances the immunosuppressive properties of human umbilical cord mesenchymal stem cells. World J Stem Cells. 15:999–1016. 2023. View Article : Google Scholar : PubMed/NCBI

Muscari C, Giordano E, Bonafè F, Govoni M, Pasini A and Guarnieri C: Priming adult stem cells by hypoxic pretreatments for applications in regenerative medicine. J Biomed Sci. 20:632013. View Article : Google Scholar : PubMed/NCBI

Zhang W, Liu L, Huo Y, Yang Y and Wang Y: Hypoxia-pretreated human MSCs attenuate acute kidney injury through enhanced angiogenic and antioxidative capacities. Biomed Res Int. 2014:4624722014.PubMed/NCBI

Collino F, Lopes JA, Corrêa S, Abdelhay E, Takiya CM, Wendt CHC, de Miranda KR, Vieyra A and Lindoso R: Adipose-derived mesenchymal stromal cells under hypoxia: Changes in extracellular vesicles secretion and improvement of renal recovery after ischemic injury. Cell Physiol Biochem. 52:1463–1483. 2019.PubMed/NCBI

Jang MJ, You D, Park JY, Kim K, Aum J, Lee C, Song G, Shin HC, Suh N, Kim YM and Kim CS: Hypoxic preconditioned mesenchymal stromal cell therapy in a rat model of renal ischemia-reperfusion injury: development of optimal protocol to potentiate therapeutic efficacy. Int J Stem Cells. 11:157–167. 2018. View Article : Google Scholar : PubMed/NCBI

Putra A, Pertiwi D, Milla MN, Indrayani UD, Jannah D, Sahariyani M, Trisnadi S and Wibowo JW: Hypoxia-preconditioned MSCs have superior effect in ameliorating renal function on acute renal failure animal model. Open Access Maced J Med Sci. 7:305–310. 2019. View Article : Google Scholar : PubMed/NCBI

Yuan F, Liu J, Zhong L, Liu P, Li T, Yang K, Gao W, Zhang G, Sun J and Zou X: Enhanced therapeutic effects of hypoxia-preconditioned mesenchymal stromal cell-derived extracellular vesicles in renal ischemic injury. Stem Cell Res Ther. 16:392025. View Article : Google Scholar : PubMed/NCBI

Overath JM, Gauer S, Obermüller N, Schubert R, Schäfer R, Geiger H and Baer PC: Short-term preconditioning enhances the therapeutic potential of adipose-derived stromal/stem cell-conditioned medium in cisplatin-induced acute kidney injury. Exp Cell Res. 342:175–183. 2016. View Article : Google Scholar : PubMed/NCBI

Yu X, Lu C, Liu H, Rao S, Cai J, Liu S, Kriegel AJ, Greene AS, Liang M and Ding X: Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury. PLoS One. 8:e627032013. View Article : Google Scholar : PubMed/NCBI

Tseng WC, Lee PY, Tsai MT, Chang FP, Chen NJ, Chien CT, Hung SC and Tarng DC: Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy. Stem Cell Res Ther. 12:3672021. View Article : Google Scholar : PubMed/NCBI

Liu P, Feng Y, Dong C, Liu D, Wu X, Wu H, Lv P and Zhou Y: Study on therapeutic action of bone marrow derived mesenchymal stem cell combined with vitamin E against acute kidney injury in rats. Life Sci. 92:829–837. 2013. View Article : Google Scholar : PubMed/NCBI

Guo Q and Wang J: Effect of combination of vitamin E and umbilical cord-derived mesenchymal stem cells on inflammation in mice with acute kidney injury. Immunopharmacol Immunotoxicol. 40:168–172. 2018. View Article : Google Scholar : PubMed/NCBI

Deng L, Li H, Su X, Zhang Y, Xu H, Fan L, Fan J, Han Q, Bai X and Zhao RC: Chlorzoxazone, a small molecule drug, augments immunosuppressive capacity of mesenchymal stem cells via modulation of FOXO3 phosphorylation. Cell Death Dis. 11:1582020. View Article : Google Scholar : PubMed/NCBI

Cai J, Yu X, Zhang B, Zhang H, Fang Y, Liu S, Liu T and Ding X: Atorvastatin improves survival of implanted stem cells in a rat model of renal ischemia-reperfusion injury. Am J Nephrol. 39:466–475. 2014. View Article : Google Scholar : PubMed/NCBI

Altun B, Yilmaz R, Aki T, Akoglu H, Zeybek D, Piskinpasa S, Uckan D, Purali N, Korkusuz P and Turgan C: Use of mesenchymal stem cells and darbepoetin improve ischemia-induced acute kidney injury outcomes. Am J Nephrol. 35:531–539. 2012. View Article : Google Scholar : PubMed/NCBI

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (Internet). National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD: 2012, https://www.ncbi.nlm.nih.gov/books/NBK548137/.

Dh HS, Sultana R, Prabhu A, Pavan SR, Mohanto S and Subramaniyan V: Biomedicine and pharmacotherapeutic effectiveness of combinatorial atorvastatin and quercetin on diabetic nephropathy: An in vitro study. Biomed Pharmacother. 174:1165332024. View Article : Google Scholar : PubMed/NCBI

Qu H, Xu H, Tian Y and Jiang X: Atorvastatin improves microenvironment to enhance the beneficial effects of BMSCs therapy in a rabbit model of acute myocardial infarction. Cell Physiol Biochem. 32:380–389. 2013. View Article : Google Scholar : PubMed/NCBI

Wu Y and Yang B: Erythropoietin Receptor/β common receptor: A shining light on acute kidney injury induced by ischemia-reperfusion. Front Immunol. 12:6977962021. View Article : Google Scholar

Ghassemi-Barghi N, Ehsanfar Z, Mohammadrezakhani O, Ashari S, Ghiabi S and Bayrami Z: Mechanistic approach for protective effect of ARA290, a specific ligand for the erythropoietin/CD131 heteroreceptor, against cisplatin-induced nephrotoxicity, the involvement of apoptosis and inflammation pathways. Inflammation. 46:342–358. 2023. View Article : Google Scholar

Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z and Gobe GC: Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int. 69:1806–1813. 2006. View Article : Google Scholar : PubMed/NCBI

Hakiminia B, Goudarzi A and Moghaddas A: Has vitamin E any shreds of evidence in cisplatin-induced toxicity. J Biochem Mol Toxicol. 33:e223492019. View Article : Google Scholar : PubMed/NCBI

Darwish MA, Abo-Youssef AM, Khalaf MM, Abo-Saif AA, Saleh IG and Abdelghany TM: Vitamin E mitigates cisplatin-induced nephrotoxicity due to reversal of oxidative/nitrosative stress, suppression of inflammation and reduction of total renal platinum accumulation. J Biochem Mol Toxicol. 31:1–9. 2017. View Article : Google Scholar

Abo-Elmaaty AMA, Behairy A, El-Naseery NI and Abdel-Daim MM: The protective efficacy of vitamin E and cod liver oil against cisplatin-induced acute kidney injury in rats. Environ Sci Pollut Res Int. 27:44412–44426. 2020. View Article : Google Scholar : PubMed/NCBI

Kim H, Yu MR, Lee H, Kwon SH, Jeon JS, Han DC and Noh H: Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells. Aging Cell. 20:e133172021. View Article : Google Scholar : PubMed/NCBI

Hu Q, Zhu B, Yang G, Jia J, Wang H, Tan R, Zhang Q, Wang L and Kantawong F: Calycosin pretreatment enhanced the therapeutic efficacy of mesenchymal stem cells to alleviate unilateral ureteral obstruction-induced renal fibrosis by inhibiting necroptosis. J Pharmacol Sci. 151:72–83. 2023. View Article : Google Scholar : PubMed/NCBI

Jiang W and Xu J: Immune modulation by mesenchymal stem cells. Cell Prolif. 53:e127122020. View Article : Google Scholar :

Huang Y, Wu Q and Tam PKH: Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications. Int J Mol Sci. 23:100232022. View Article : Google Scholar : PubMed/NCBI

Zhou J and Shi Y: Mesenchymal stem/stromal cells (MSCs): Origin, immune regulation, and clinical applications. Cell Mol Immunol. 20:555–557. 2023. View Article : Google Scholar : PubMed/NCBI

Wang Y, Fang J, Liu B, Shao C and Shi Y: Reciprocal regulation of mesenchymal stem cells and immune responses. Cell Stem Cell. 29:1515–1530. 2022. View Article : Google Scholar : PubMed/NCBI

Li P, Ou Q, Shi S and Shao C: Immunomodulatory properties of mesenchymal stem cells/dental stem cells and their therapeutic applications. Cell Mol Immunol. 20:558–569. 2023. View Article : Google Scholar : PubMed/NCBI

Wang S, Umrath F, Cen W, Salgado AJ, Reinert S and Alexander D: Pre-conditioning with IFN-γ and hypoxia enhances the angiogenic potential of iPSC-Derived MSC secretome. Cells. 11:9882022. View Article : Google Scholar

Wu J, Wu J, Xiang W, Gong Y, Feng D, Fang S, Wu Y, Liu Z, Li Y, Chen R, et al: Engineering exosomes derived from TNF-α preconditioned IPFP-MSCs enhance both yield and therapeutic efficacy for osteoarthritis. J Nanobiotechnology. 22:5552024. View Article : Google Scholar

Nakao Y, Fukuda T, Zhang Q, Sanui T, Shinjo T, Kou X, Chen C, Liu D, Watanabe Y, Hayashi C, et al: Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss. Acta Biomater. 122:306–324. 2021. View Article : Google Scholar

Ma T, Wang X, Jiao Y, Wang H, Qi Y, Gong H, Zhang L and Jiang D: Interleukin 17 (IL-17)-induced mesenchymal stem cells prolong the survival of allogeneic skin grafts. Ann Transplant. 23:615–621. 2018. View Article : Google Scholar : PubMed/NCBI

Zhao C, Li J, Cai H, Wu D, Tao S, Pi C, Zhu L, Xu N and Zhang T: An injectable hydrogel scaffold with IL-1β-activated MSC-derived exosomes for the treatment of endometritis. Biomater Sci. 11:1422–1436. 2023. View Article : Google Scholar : PubMed/NCBI

Pezzanite LM, Chow L, Phillips J, Griffenhagen GM, Moore AR, Schaer TP, Engiles JB, Werpy N, Gilbertie J, Schnabel LV, et al: TLR-activated mesenchymal stromal cell therapy and antibiotics to treat multi-drug resistant Staphylococcal septic arthritis in an equine model. Ann Transl Med. 10:11572022. View Article : Google Scholar : PubMed/NCBI

Giuliani M, Bennaceur-Griscelli A, Nanbakhsh A, Oudrhiri N, Chouaib S, Azzarone B, Durrbach A and Lataillade JJ: TLR ligands stimulation protects MSC from NK killing. Stem Cells. 32:290–300. 2014. View Article : Google Scholar

Kwon YW, Heo SC, Jeong GO, Yoon JW, Mo WM, Lee MJ, Jang IH, Kwon SM, Lee JS and Kim JH: Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis. Biochim Biophys Acta. 1832:2136–2144. 2013. View Article : Google Scholar : PubMed/NCBI

Heo SC, Jeon ES, Lee IH, Kim HS, Kim MB and Kim JH: Tumor necrosis factor-α-activated human adipose tissue-derived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms. J Invest Dermatol. 131:1559–1567. 2011. View Article : Google Scholar : PubMed/NCBI

Bai X, Xi J, Bi Y, Zhao X, Bing W, Meng X, Liu Y, Zhu Z and Song G: TNF-alpha promotes survival and migration of MSCs under oxidative stress via NF-κB pathway to attenuate intimal hyperplasia in vein grafts. J Cell Mol Med. 21:2077–2091. 2017. View Article : Google Scholar : PubMed/NCBI

Zhao L, Hu C, Zhang P, Jiang H and Chen J: Melatonin preconditioning is an effective strategy for mesenchymal stem cell-based therapy for kidney disease. J Cell Mol Med. 24:25–33. 2020. View Article : Google Scholar

Alzahrani FA: Melatonin improves therapeutic potential of mesenchymal stem cells-derived exosomes against renal ischemia-reperfusion injury in rats. Am J Transl Res. 11:2887–2907. 2019.PubMed/NCBI

Aussel C, Baudry N, Grosbot M, Caron C, Vicaut E, Banzet S and Peltzer JS: IL-1β primed mesenchymal stromal cells moderate hemorrhagic shock-induced organ injuries. Stem Cell Res Ther. 12:4382021. View Article : Google Scholar

Bai M, Zhang L, Fu B, Bai J, Zhang Y, Cai G, Bai X, Feng Z, Sun S and Chen X: IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway. Kidney Int. 93:814–825. 2018. View Article : Google Scholar

Chen HH, Lin KC, Wallace CG, Chen YT, Yang CC, Leu S, Chen YC, Sun CK, Tsai TH, Chen YL, et al: Additional benefit of combined therapy with melatonin and apoptotic adipose-derived mesenchymal stem cell against sepsis-induced kidney injury. J Pineal Res. 57:16–32. 2014. View Article : Google Scholar : PubMed/NCBI

Kanai R, Nakashima A, Doi S, Kimura T, Yoshida K, Maeda S, Ishiuchi N, Yamada Y, Ike T, Doi T, et al: Interferon-gamma enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis. Sci Rep. 11:8502021. View Article : Google Scholar

Mias C, Trouche E, Seguelas MH, Calcagno F, Dignat-George F, Sabatier F, Piercecchi-Marti MD, Daniel L, Bianchi P, Calise D, et al: Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells. 26:1749–1757. 2008. View Article : Google Scholar : PubMed/NCBI

Zhao J, Young YK, Fradette J and Eliopoulos N: Melatonin pretreatment of human adipose tissue-derived mesenchymal stromal cells enhances their prosurvival and protective effects on human kidney cells. Am J Physiol Renal Physiol. 308:F1474–F1483. 2015. View Article : Google Scholar : PubMed/NCBI

Zhou S, Qiao YM, Liu YG, Liu D, Hu JM, Liao J, Li M, Guo Y, Fan LP, Li LY and Zhao M: Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury. Cell Biosci. 10:1302020. View Article : Google Scholar : PubMed/NCBI

Wang S, Wang G, Zhang L, Li F, Liu K, Wang Y, Shi Y and Cao K: Interleukin-17 promotes nitric oxide-dependent expression of PD-L1 in mesenchymal stem cells. Cell Biosci. 10:732020. View Article : Google Scholar : PubMed/NCBI

Han X, Yang Q, Lin L, Xu C, Zheng C, Chen X, Han Y, Li M, Cao W, Cao K, et al: Interleukin-17 enhances immunosuppression by mesenchymal stem cells. Cell Death Differ. 21:1758–1768. 2014. View Article : Google Scholar : PubMed/NCBI

Wang C, Jiang C, Yang Y, Xi C, Yin Y, Wu H and Qian C: Therapeutic potential of HUC-MSC-exos primed with IFN-γ against LPS-induced acute lung injury. Iran J Basic Med Sci. 27:375–382. 2024.

Stazi M, Negro S, Megighian A, D'Este G, Solimena M, Jockers R, Lista F, Montecucco C and Rigoni M: Melatonin promotes regeneration of injured motor axons via MT₁ receptors. J Pineal Res. 70:e126952021. View Article : Google Scholar

Romero A, Morales-Garcia JA and Ramos E: Melatonin: A multitasking indoleamine to modulate hippocampal neurogenesis. Neural Regen Res. 18:503–505. 2023. View Article : Google Scholar

Reiter RJ, Tan DX, Poeggeler B, Menendez-Pelaez A, Chen LD and Saarela S: Melatonin as a free radical scavenger: Implications for aging and age-related diseases. Ann N Y Acad Sci. 719:1–12. 1994. View Article : Google Scholar : PubMed/NCBI

Reiter RJ, Tan DX and Fuentes-Broto L: Melatonin: A multitasking molecule. Prog Brain Res. 181:127–151. 2010. View Article : Google Scholar : PubMed/NCBI

Reiter RJ: Melatonin: The chemical expression of darkness. Mol Cell Endocrinol. 79:C153–C158. 1991. View Article : Google Scholar : PubMed/NCBI

Feng ZY, Yang SD, Wang T and Guo S: Effect of melatonin for regulating mesenchymal stromal cells and derived extracellular vesicles. Front Cell Dev Biol. 9:7179132021. View Article : Google Scholar : PubMed/NCBI

Elzainy A, El Sadik A and Altowayan WM: Comparison between the regenerative and therapeutic impacts of bone marrow mesenchymal stem cells and adipose mesenchymal stem cells pre-treated with melatonin on liver fibrosis. Biomolecules. 14:2972024. View Article : Google Scholar : PubMed/NCBI

Zou D, Liao J, Xiao M, Liu L and Xu M: Melatonin alleviates hyperoxia-induced lung injury through elevating MSC exosomal miR-18a-5p expression to repress PUM2 signaling. FASEB J. 38:e700122024. View Article : Google Scholar : PubMed/NCBI

Rafiq H, Ayaz M, Khan HA, Iqbal M, Quraish S, Afridi SG, Khan A, Khan B, Sher A, Siraj F and Shams S: Therapeutic potential of stem cell and melatonin on the reduction of CCl4-induced liver fibrosis in experimental mice model. Braz J Biol. 84:e2530612022. View Article : Google Scholar : PubMed/NCBI

Mintoft A, Vallatos A and Robertson NJ: Mesenchymal stromal cell therapy for hypoxic ischemic encephalopathy: Future directions for combination therapy with hypothermia and/or melatonin. Semin Perinatol. 48:1519292024. View Article : Google Scholar : PubMed/NCBI

Lee JH, Han YS and Lee SH: Melatonin-induced PGC-1α improves angiogenic potential of mesenchymal stem cells in hindlimb ischemia. Biomol Ther (Seoul). 28:240–249. 2020. View Article : Google Scholar

Hanna M, Elnassag SS, Mohamed DH, Elbaset MA, Shaker O, Khowailed EA and Gouda SAA: Melatonin and mesenchymal stem cells co-administration alleviates chronic obstructive pulmonary disease via modulation of angiogenesis at the vascular-alveolar unit. Pflugers Arch. 476:1155–1168. 2024. View Article : Google Scholar : PubMed/NCBI

Tripathy S and Bhattamisra SK: Cellular signalling of melatonin and its role in metabolic disorders. Mol Biol Rep. 52:1932025. View Article : Google Scholar : PubMed/NCBI

Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS and Slominski AT: Melatonin membrane receptors in peripheral tissues: Distribution and functions. Mol Cell Endocrinol. 351:152–166. 2012. View Article : Google Scholar : PubMed/NCBI

Charif SE and Dorfman VB: Melatonin, modulation of hypothalamic activity, and reproduction. Vitam Horm. 127:283–303. 2025. View Article : Google Scholar : PubMed/NCBI

Saberi K, Pasbakhsh P, Omidi A, Borhani-Haghighi M, Nekoonam S, Omidi N, Ghasemi S and Kashani IR: Melatonin preconditioning of bone marrow-derived mesenchymal stem cells promotes their engraftment and improves renal regeneration in a rat model of chronic kidney disease. J Mol Histol. 50:129–140. 2019. View Article : Google Scholar : PubMed/NCBI

Yasuoka Y, Izumi Y, Fukuyama T, Oshima T, Yamazaki T, Uematsu T, Kobayashi N, Nanami M, Shimada Y, Nagaba Y, et al: Tubular endogenous erythropoietin protects renal function against ischemic reperfusion injury. Int J Mol Sci. 25:12232024. View Article : Google Scholar : PubMed/NCBI

Bi B, Guo J, Marlier A, Lin SR and Cantley LG: Erythropoietin expands a stromal cell population that can mediate renoprotection. Am J Physiol Renal Physiol. 295:F1017–F1022. 2008. View Article : Google Scholar : PubMed/NCBI

Zuo L, Li DD, Ma XX, Shi SH, Lyu DC, Shen J, Zhang WF, Gao EH and Cao JM: Erythropoietin promotes myocardial infarction repair in mice by improving the function of Sca-1(+) stem cells. Sheng Li Xue Bao. 75:36–48. 2023.PubMed/NCBI

Wu YW, Comstock BA, Gonzalez FF, Mayock DE, Goodman AM, Maitre NL, Chang T, Van Meurs KP, Lampland AL, Bendel-Stenzel E, et al: Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns. N Engl J Med. 387:148–159. 2022. View Article : Google Scholar : PubMed/NCBI

Bianchi VE and von Haehling S: The treatment of chronic anemia in heart failure: A global approach. Clin Res Cardiol. 113:1117–1136. 2024. View Article : Google Scholar

Jun JH, Jun NH, Shim JK, Shin EJ and Kwak YL: Erythropoietin protects myocardium against ischemia-reperfusion injury under moderate hyperglycemia. Eur J Pharmacol. 745:1–9. 2014. View Article : Google Scholar : PubMed/NCBI

Zhou S, Liu YG, Zhang Y, Hu JM, Liu D, Chen H, Li M, Guo Y, Fan LP, Li LY and Zhao M: Bone mesenchymal stem cells pretreated with erythropoietin enhance the effect to ameliorate cyclosporine A-induced nephrotoxicity in rats. J Cell Biochem. 119:8220–8232. 2018. View Article : Google Scholar : PubMed/NCBI

Verdino P, Lee SL, Cooper FN, Cottle SR, Grealish PF, Hu CC, Meyer CM, Lin J, Copeland V, Porter G, et al: Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure. Br J Pharmacol. 180:1965–1980. 2023. View Article : Google Scholar : PubMed/NCBI

Samuel CS and Hewitson TD: Relaxin in cardiovascular and renal disease. Kidney Int. 69:1498–1502. 2006. View Article : Google Scholar : PubMed/NCBI

Martins RC, Pintalhao M, Leite-Moreira A and Castro-Chaves P: Relaxin and the cardiovascular system: From basic science to clinical practice. Curr Mol Med. 20:167–184. 2020. View Article : Google Scholar

Feiteng C, Lei C, Deng L, Chaoliang X, Zijie X, Yi S and Minglei S: Relaxin inhibits renal fibrosis and the epithelial-to-mesenchymal transition via the Wnt/beta-catenin signaling pathway. Ren Fail. 44:513–524. 2022. View Article : Google Scholar : PubMed/NCBI

Conrad KP, von Versen-Hoynck F and Baker VL: Potential role of the corpus luteum in maternal cardiovascular adaptation to pregnancy and preeclampsia risk. Am J Obstet Gynecol. 226:683–699. 2022. View Article : Google Scholar

Bathgate RA, Ivell R, Sanborn BM, Sherwood OD and Summers RJ: International union of pharmacology LVII: Recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev. 58:7–31. 2006. View Article : Google Scholar : PubMed/NCBI

Li Y, Shen M, Ferens D, Broughton BRS, Murthi P, Saini S, Widdop RE, Ricardo SD, Pinar AA and Samuel CS: Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension. Br J Pharmacol. 178:1164–1181. 2021. View Article : Google Scholar : PubMed/NCBI

Li H, Lu W, Wang A, Jiang H and Lyu J: Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: Estimates from global burden of disease 2017. J Diabetes Investig. 12:346–356. 2021. View Article : Google Scholar

Huuskes BM, Wise AF, Cox AJ, Lim EX, Payne NL, Kelly DJ, Samuel CS and Ricardo SD: Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy. FASEB J. 29:540–553. 2015. View Article : Google Scholar

Badawi A, Jefferson OC, Huuskes BM, Ricardo SD, Kerr PG, Samuel CS and Murthi P: A novel approach to enhance the regenerative potential of circulating endothelial progenitor cells in patients with end-stage kidney disease. Biomedicines. 10:8832022. View Article : Google Scholar : PubMed/NCBI

Feng G, Zhang J, Li Y, Nie Y, Zhu D, Wang R, Liu J, Gao J, Liu N, He N, et al: IGF-1 C domain-modified hydrogel enhances cell therapy for AKI. J Am Soc Nephrol. 27:2357–2369. 2016. View Article : Google Scholar : PubMed/NCBI

Fu Z, Chu Y, Geng X, Ma Y, Chi K, Song C, Liao S, Hong Q, Wu D and Wang Y: Artificial kidney capsule packed with mesenchymal stem cell-laden hydrogel for the treatment of rhabdomyolysis-induced acute kidney injury. ACS Biomater Sci Eng. 8:1726–1734. 2022. View Article : Google Scholar : PubMed/NCBI

Geng X, Hong Q, Wang W, Zheng W, Li O, Cai G, Chen X and Wu D: Biological membrane-packed mesenchymal stem cells treat acute kidney disease by ameliorating mitochondrial-related apoptosis. Sci Rep. 7:411362017. View Article : Google Scholar : PubMed/NCBI

Han DS, Erickson C, Hansen KC, Kirkbride-Romeo L, He Z, Rodell CB and Soranno DE: Mesenchymal stem cells delivered locally to ischemia-reperfused kidneys via injectable hyaluronic acid hydrogels decrease extracellular matrix remodeling 1 month after injury in male mice. Cells. 12:17712023. View Article : Google Scholar : PubMed/NCBI

Huang S, Li Y, Wang X, Ma X and Zhang X: Injectable co-gels of collagen and decellularized vascular matrix improve MSC-based therapy for acute kidney injury. J Biomater Sci Polym Ed. 28:2186–2195. 2017. View Article : Google Scholar : PubMed/NCBI

Najafi H, Abolmaali SS, Heidari R, Valizadeh H, Tamaddon AM and Azarpira N: Integrin receptor-binding nanofibrous peptide hydrogel for combined mesenchymal stem cell therapy and nitric oxide delivery in renal ischemia/reperfusion injury. Stem Cell Res Ther. 13:3442022. View Article : Google Scholar : PubMed/NCBI

Xu Y, Shi T, Xu A and Zhang L: 3D spheroid culture enhances survival and therapeutic capacities of MSCs injected into ischemic kidney. J Cell Mol Med. 20:1203–1213. 2016. View Article : Google Scholar : PubMed/NCBI

Wang H, Shang Y, Chen X, Wang Z, Zhu D, Liu Y, Zhang C, Chen P, Wu J, Wu L, et al: Delivery of MSCs with a hybrid beta-sheet peptide hydrogel consisting IGF-1C domain and D-Form peptide for acute kidney injury therapy. Int J Nanomedicine. 15:4311–4324. 2020. View Article : Google Scholar :

Ho TC, Chang CC, Chan HP, Chung TW, Shu CW, Chuang KP, Duh TH, Yang MH and Tyan YC: Hydrogels: Properties and applications in biomedicine. Molecules. 27:29022022. View Article : Google Scholar : PubMed/NCBI

Hameed H, Faheem S, Paiva-Santos AC, Sarwar HS and Jamshaid M: A Comprehensive review of hydrogel-based drug delivery systems: classification, properties, recent trends, and applications. AAPS PharmSciTech. 25:642024. View Article : Google Scholar : PubMed/NCBI

Seliktar D: Designing cell-compatible hydrogels for biomedical applications. Science. 336:1124–1128. 2012. View Article : Google Scholar : PubMed/NCBI

Yap JX, Leo CP, Yasin NH, Show PL, Chu DT, Singh V and Derek CJC: Recent advances of natural biopolymeric culture scaffold: Synthesis and modification. Bioengineered. 13:2226–2247. 2022. View Article : Google Scholar : PubMed/NCBI

Wechsler ME, Rao VV, Borelli AN and Anseth KS: Engineering the MSC Secretome: A hydrogel focused approach. Adv Healthc Mater. 10:e20019482021. View Article : Google Scholar : PubMed/NCBI

Peng J, Yang T, Chen S, Deng N, Luo X, Liao R and Su B: Utilization of hydrogels in mesenchymal stem cell-based therapy for kidney diseases. Tissue Eng Part B Rev. 30:315–326. 2024. View Article : Google Scholar

Zhao L, Zhou Y, Zhang J, Liang H, Chen X and Tan H: Natural polymer-based hydrogels: From polymer to biomedical applications. Pharmaceutics. 15:25142023. View Article : Google Scholar : PubMed/NCBI

Zhang M and Zhao X: Alginate hydrogel dressings for advanced wound management. Int J Biol Macromol. 162:1414–1428. 2020. View Article : Google Scholar : PubMed/NCBI

Kou SG, Peters LM and Mucalo MR: Chitosan: A review of sources and preparation methods. Int J Biol Macromol. 169:85–94. 2021. View Article : Google Scholar

Yazdi MK, Taghizadeh A, Taghizadeh M, Stadler FJ, Farokhi M, Mottaghitalab F, Zarrintaj P, Ramsey JD, Seidi F, Saeb MR and Mozafari M: Agarose-based biomaterials for advanced drug delivery. J Control Release. 326:523–543. 2020. View Article : Google Scholar

Burdick JA and Prestwich GD: Hyaluronic acid hydrogels for biomedical applications. Adv Mater. 23:H41–H56. 2011. View Article : Google Scholar : PubMed/NCBI

Hu X, Xia Z and Cai K: Recent advances in 3D hydrogel culture systems for mesenchymal stem cell-based therapy and cell behavior regulation. J Mater Chem B. 10:1486–1507. 2022. View Article : Google Scholar : PubMed/NCBI

Axpe E and Oyen ML: Applications of alginate-based bioinks in 3D Bioprinting. Int J Mol Sci. 17:19762016. View Article : Google Scholar : PubMed/NCBI

Troy E, Tilbury MA, Power AM and Wall JG: Nature-based biomaterials and their application in biomedicine. Polymers (Basel). 13:33212021. View Article : Google Scholar : PubMed/NCBI

Lee KY and Mooney DJ: Alginate: Properties and biomedical applications. Prog Polym Sci. 37:106–126. 2012. View Article : Google Scholar

Khatab S, Leijs MJ, van Buul G, Haeck J, Kops N, Nieboer M, Bos PK, Verhaar JAN, Bernsen M and van Osch GJVM: MSC encapsulation in alginate microcapsules prolongs survival after intra-articular injection, a longitudinal in vivo cell and bead integrity tracking study. Cell Biol Toxicol. 36:553–570. 2020. View Article : Google Scholar : PubMed/NCBI

Mohammadi M, Luong JC, Rodriguez SM, Cao R, Wheeler AE, Lau H, Li S, Shabestari SK, Chadarevian JP, Alexander M, et al: Controlled release of stem cell secretome attenuates inflammatory response against implanted biomaterials. Adv Healthc Mater. 9:e19018742020. View Article : Google Scholar : PubMed/NCBI

Bari E, Scocozza F, Perteghella S, Sorlini M, Auricchio F, Torre ML and Conti M: 3D bioprinted scaffolds containing mesenchymal stem/stromal lyosecretome: Next generation controlled release device for bone regenerative medicine. Pharmaceutics. 13:5152021. View Article : Google Scholar : PubMed/NCBI

Huang Y, Onyeri S, Siewe M, Moshfeghian A and Madihally SV: In vitro characterization of chitosan-gelatin scaffolds for tissue engineering. Biomaterials. 26:7616–7627. 2005. View Article : Google Scholar : PubMed/NCBI

Wagenbrenner M, Mayer-Wagner S, Rudert M, Holzapfel BM and Weissenberger M: Combinations of hydrogels and mesenchymal stromal cells (MSCs) for cartilage tissue engineering-A review of the literature. Gels. 7:2172021. View Article : Google Scholar : PubMed/NCBI

Gao J, Liu R, Wu J, Liu Z, Li J, Zhou J, Hao T, Wang Y, Du Z, Duan C and Wang C: The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury. Biomaterials. 33:3673–3681. 2012. View Article : Google Scholar : PubMed/NCBI

Lee CH, Singla A and Lee Y: Biomedical applications of collagen. Int J Pharm. 221:1–22. 2001. View Article : Google Scholar : PubMed/NCBI

Huang M, Li D, Chen J, Ji Y, Su T, Chen Y, Zhang Y, Wang Y, Li F, Chen S, et al: Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice. Stem Cell Res Ther. 13:1282022. View Article : Google Scholar : PubMed/NCBI

Huang Q, Zou Y, Arno MC, Chen S, Wang T, Gao J, Dove AP and Du J: Hydrogel scaffolds for differentiation of adipose-derived stem cells. Chem Soc Rev. 46:6255–6275. 2017. View Article : Google Scholar : PubMed/NCBI

La Manna G, Bianchi F, Cappuccilli M, Cenacchi G, Tarantino L, Pasquinelli G, Valente S, Della Bella E, Cantoni S, Claudia C, et al: Mesenchymal stem cells in renal function recovery after acute kidney injury: Use of a differentiating agent in a rat model. Cell Transplant. 20:1193–1208. 2011. View Article : Google Scholar

Rohanizadeh R, Swain MV and Mason RS: Gelatin sponges (Gelfoam) as a scaffold for osteoblasts. J Mater Sci Mater Med. 19:1173–1182. 2008. View Article : Google Scholar

Bello AB, Kim D, Kim D, Park H and Lee SH: Engineering and functionalization of gelatin biomaterials: From cell culture to medical applications. Tissue Eng Part B Rev. 26:164–180. 2020. View Article : Google Scholar : PubMed/NCBI

Helminger M, Wu B, Kollmann T, Benke D, Schwahn D, Pipich V, Faivre D, Zahn D and Cölfen H: Synthesis and characterization of gelatin-based magnetic hydrogels. Adv Funct Mater. 24:3187–3196. 2014. View Article : Google Scholar

Mushtaq F, Raza ZA, Batool SR, Zahid M, Onder OC, Rafique A and Nazeer MA: Preparation, properties, and applications of gelatin-based hydrogels (GHs) in the environmental, technological, and biomedical sectors. Int J Biol Macromol. 218:601–633. 2022. View Article : Google Scholar : PubMed/NCBI

Sobreiro-Almeida R, Quinteira R and Neves NM: Renal regeneration: The role of extracellular matrix and current ECM-based tissue engineered strategies. Adv Healthc Mater. 10:e21001602021. View Article : Google Scholar : PubMed/NCBI

Song JJ, Guyette JP, Gilpin SE, Gonzalez G, Vacanti JP and Ott HC: Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med. 19:646–651. 2013. View Article : Google Scholar : PubMed/NCBI

Kim JW, Nam SA, Yi J, Kim JY, Lee JY, Park SY, Sen T, Choi YM, Lee JY, Kim HL, et al: Kidney decellularized extracellular matrix enhanced the vascularization and maturation of human kidney organoids. Adv Sci (Weinh). 9:e21035262022. View Article : Google Scholar : PubMed/NCBI

Saldin LT, Cramer MC, Velankar SS, White LJ and Badylak SF: Extracellular matrix hydrogels from decellularized tissues: Structure and function. Acta Biomater. 49:1–15. 2017. View Article : Google Scholar :

Zhou C, Zhou L, Liu J, Xu L, Xu Z, Chen Z, Ge Y, Zhao F, Wu R, Wang X, et al: Kidney extracellular matrix hydrogel enhances therapeutic potential of adipose-derived mesenchymal stem cells for renal ischemia reperfusion injury. Acta Biomater. 115:250–263. 2020. View Article : Google Scholar : PubMed/NCBI

Li J, Chee HL, Chong YT, Chan BQY, Xue K, Lim PC, Loh XJ and Wang F: Hofmeister effect mediated strong PHEMA-Gelatin hydrogel actuator. ACS Appl Mater Interfaces. 14:23826–23838. 2022. View Article : Google Scholar : PubMed/NCBI

Zullo JA, Nadel EP, Rabadi MM, Baskind MJ, Rajdev MA, Demaree CM, Vasko R, Chugh SS, Lamba R, Goligorsky MS and Ratliff BB: The secretome of hydrogel-coembedded endothelial progenitor cells and mesenchymal stem cells instructs macrophage polarization in endotoxemia. Stem Cells Transl Med. 4:852–861. 2015. View Article : Google Scholar : PubMed/NCBI

Tietze S, Kräter M, Jacobi A, Taubenberger A, Herbig M, Wehner R, Schmitz M, Otto O, List C, Kaya B, et al: Spheroid culture of mesenchymal stromal cells results in morphorheological properties appropriate for improved microcirculation. Adv Sci (Weinh). 6:18021042019. View Article : Google Scholar : PubMed/NCBI

Shoma Suresh K, Bhat S, Guru BR, Muttigi MS and Seetharam RN: A nanocomposite hydrogel delivery system for mesenchymal stromal cell secretome. Stem Cell Res Ther. 11:2052020. View Article : Google Scholar : PubMed/NCBI

Xu X, Jha AK, Harrington DA, Farach-Carson MC and Jia X: Hyaluronic acid-based hydrogels: From a natural polysaccharide to complex networks. Soft Matter. 8:3280–3294. 2012. View Article : Google Scholar : PubMed/NCBI

Kleinman HK and Martin GR: Matrigel: Basement membrane matrix with biological activity. Semin Cancer Biol. 15:378–386. 2005. View Article : Google Scholar : PubMed/NCBI

Goetzke R, Franzen J, Ostrowska A, Vogt M, Blaeser A, Klein G, Rath B, Fischer H, Zenke M and Wagner W: Does soft really matter? Differentiation of induced pluripotent stem cells into mesenchymal stromal cells is not influenced by soft hydrogels. Biomaterials. 156:147–158. 2018. View Article : Google Scholar

Najafi H, Abolmaali SS, Heidari R, Valizadeh H, Jafari M, Tamaddon AM and Azarpira N: Nitric oxide releasing nanofibrous Fmoc-dipeptide hydrogels for amelioration of renal ischemia/reperfusion injury. J Control Release. 337:1–13. 2021. View Article : Google Scholar : PubMed/NCBI

Lin RZ and Chang HY: Chang, recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J. 3:1172–1184. 2008. View Article : Google Scholar : PubMed/NCBI

Ryu NE, Lee SH and Park H: Spheroid culture system methods and applications for mesenchymal stem cells. Cells. 8:16202019. View Article : Google Scholar : PubMed/NCBI

Yang WY, Chen LC, Jhuang YT, Lin YJ, Hung PY, Ko YC, Tsai MY, Lee YW, Hsu LW, Yeh CK, et al: Injection of hybrid 3D spheroids composed of podocytes, mesenchymal stem cells, and vascular endothelial cells into the renal cortex improves kidney function and replenishes glomerular podocytes. Bioeng Transl Med. 6:e102122021. View Article : Google Scholar : PubMed/NCBI

Xu H, Chen C, Hu L and Hou J: Gene-modified mesenchymal stem cell-based therapy in renal ischemia-reperfusion injury. Curr Gene Ther. 17:453–460. 2017. View Article : Google Scholar

Roudkenar MH, Halabian R, Tehrani HA, Amiri F, Jahanian-Najafabadi A, Roushandeh AM, Abbasi-Malati Z and Kuwahara Y: Lipocalin 2 enhances mesenchymal stem cell-based cell therapy in acute kidney injury rat model. Cytotechnology. 70:103–117. 2018. View Article : Google Scholar :

Ni W, Zhang Y and Yin Z: The protective mechanism of Klotho gene-modified bone marrow mesenchymal stem cells on acute kidney injury induced by rhabdomyolysis. Regen Ther. 18:255–267. 2021. View Article : Google Scholar : PubMed/NCBI

Zhang J, Yuan Z, Zhong W and Wei Y: Stem cell as vehicles of antibody in treatment of lymphoma: A novel and potential targeted therapy. Stem Cell Rev Rep. 17:829–841. 2021. View Article : Google Scholar

Chen Y, Qian H, Zhu W, Zhang X, Yan Y, Ye S, Peng X, Li W and Xu W: Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev. 20:103–113. 2011. View Article : Google Scholar

Hagiwara M, Shen B, Chao L and Chao J: Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosivgs and inflammation. Hum Gene Ther. 19:807–819. 2008. View Article : Google Scholar : PubMed/NCBI

Liu N, Patzak A and Zhang J: CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury. Am J Physiol Renal Physiol. 305:F1064–F1073. 2013. View Article : Google Scholar : PubMed/NCBI

Liu N, Tian J, Cheng J and Zhang J: Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney. J Cell Biochem. 114:2677–2689. 2013. View Article : Google Scholar : PubMed/NCBI

Liu N, Wang H, Han G, Cheng J, Hu W and Zhang J: Enhanced proliferation and differentiation of HO-1 gene-modified bone marrow-derived mesenchymal stem cells in the acute injured kidney. Int J Mol Med. 42:946–956. 2018.PubMed/NCBI

Liu N, Wang H, Han G, Tian J, Hu W and Zhang J: Alleviation of apoptosis of bone marrow-derived mesenchymal stem cells in the acute injured kidney by heme oxygenase-1 gene modification. Int J Biochem Cell Biol. 69:85–94. 2015. View Article : Google Scholar : PubMed/NCBI

da Cunha MGM, Zia S, Beckmann DV, Carlon MS, Arcolino FO, Albersen M, Pippi NL, Graça DL, Gysemans C, Carmeliet P, et al: Vascular endothelial growth factor up-regulation in human amniotic fluid stem cell enhances nephroprotection after ischemia-reperfusion injury in the rat. Crit Care Med. 45:e86–e96. 2017. View Article : Google Scholar

Yuzeng Q, Weiyang H, Xin G, Qingson Z, Youlin K and Ke R: Effects of transplantation with marrow-derived mesenchymal stem cells modified with survivin on renal ischemia-reperfusion injury in mice. Yonsei Med J. 55:1130–1137. 2014. View Article : Google Scholar : PubMed/NCBI

Pawitan JA, Bui TA, Mubarok W, Antarianto RD, Nurhayati RW, Dilogo IH and Oceandy D: Enhancement of the therapeutic capacity of mesenchymal stem cells by genetic modification: A systematic review. Front Cell Dev Biol. 8:5877762020. View Article : Google Scholar : PubMed/NCBI

Kresse JC, Gregersen E, Atay JCL, Eijken M and Nørregaard R: Does the route matter? A preclinical review of mesenchymal stromal cell delivery to the kidney. APMIS. 131:687–697. 2023. View Article : Google Scholar : PubMed/NCBI

Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC and Pelletier MP: Stem cell transplantation: The lung barrier. Transplant Proc. 39:573–576. 2007. View Article : Google Scholar : PubMed/NCBI

Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA and Cox CS Jr: Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev. 18:683–692. 2009. View Article : Google Scholar

Schmuck EG, Koch JM, Centanni JM, Hacker TA, Braun RK, Eldridge M, Hei DJ, Hematti P and Raval AN: Biodistribution and clearance of human mesenchymal stem cells by quantitative three-dimensional cryo-imaging after intravenous infusion in a rat lung injury model. Stem Cells Transl Med. 5:1668–1675. 2016. View Article : Google Scholar : PubMed/NCBI

Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J and Stewart DJ; Canadian Critical Care Trials Group: Safety of cell therapy with mesenchymal stromal cells (SafeCell): A systematic review and meta-analysis of clinical trials. PLoS One. 7:e475592012. View Article : Google Scholar : PubMed/NCBI

Kansu E: Thrombosis in stem cell transplantation. Hematology. 17(Suppl 1): S159–S162. 2012. View Article : Google Scholar : PubMed/NCBI

Cui LL, Kerkelä E, Bakreen A, Nitzsche F, Andrzejewska A, Nowakowski A, Janowski M, Walczak P, Boltze J, Lukomska B and Jolkkonen J: The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res Ther. 6:112015. View Article : Google Scholar : PubMed/NCBI

Sanchez-Diaz M, Quiñones-Vico MI, de la Torre RS, Montero-Vílchez T, Sierra-Sánchez A, Molina-Leyva A and Arias-Santiago S: Biodistribution of mesenchymal stromal cells after administration in animal models and humans: A systematic review. J Clin Med. 10:29252021. View Article : Google Scholar : PubMed/NCBI

Bagno LL, Salerno AG, Balkan W and Hare JM: Mechanism of Action of Mesenchymal Stem Cells (MSCs): Impact of delivery method. Expert Opin Biol Ther. 22:449–463. 2022. View Article : Google Scholar :

Kim K, Bou-Ghannam S, Kameishi S, Oka M, Grainger DW and Okano T: Allogeneic mesenchymal stem cell sheet therapy: A new frontier in drug delivery systems. J Control Release. 330:696–704. 2021. View Article : Google Scholar